Isomorphic Labs raises $2.1B to push AI-designed drugs into the clinic DeepMind spin-out's Series B, second-largest biotech round ever, funds its IsoDDE engine and a first in-house trial by end-2026 誰の金か ·12 論調 ·6月24日